Direct powder extrusion 3D printing of praziquantel to overcome neglected disease formulation challenges in paediatric populations

dc.creatorBoniatti, Janine
dc.creatorJanuskaite, Patricija
dc.creatorFonseca, Laís B. da
dc.creatorViçosa, Alessandra L.
dc.creatorAmendoeira, Fábio C.
dc.creatorTuleu, Catherine
dc.creatorBasit, Abdul W.
dc.creatorGoyanes, Alvaro
dc.creatorRé, Maria Inês
dc.date.accessioned2022-05-03T18:25:21Z
dc.date.accessioned2023-09-05T12:22:00Z
dc.date.available2022-05-03T18:25:21Z
dc.date.available2023-09-05T12:22:00Z
dc.date.created2022-05-03T18:25:21Z
dc.date.issued2021
dc.identifierBONIATTI, Janine et al. Direct powder extrusion 3D printing of praziquantel to overcome neglected disease formulation challenges in paediatric populations. Pharmaceutics, v. 13, n. 8, p. 1-20, 2021.
dc.identifier1999-4923
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/52517
dc.identifier10.3390/pharmaceutics13081114
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8654551
dc.languageen
dc.publisherMDPI
dc.rightsopen access
dc.titleDirect powder extrusion 3D printing of praziquantel to overcome neglected disease formulation challenges in paediatric populations
dc.typeArticle


Este ítem pertenece a la siguiente institución